For the quarter ending 2026-03-31, IOSP made $453.2M in revenue. $30.4M in net income. Net profit margin of 6.71%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net sales | 453.2 | 455* | 441.9 | 439.7 |
| Cost of goods sold | 329.7 | 323* | 325.2 | 316.5 |
| Gross profit | 123.5 | 132* | 116.7 | 123.2 |
| Selling, general and administrative | 78.5 | 129* | 71.9 | 74.6 |
| Research and development | 13.2 | 10* | 13.7 | 13.6 |
| Adjustment to fair value of contingent consideration | -4.7 | 9* | -17.7 | 0.8 |
| Restructuring charge | - | -2* | 0.9 | - |
| Impairment of property, plant and equipment | - | -46* | 22.9 | - |
| Impairment of intangible assets | - | -38* | 19.1 | - |
| Profit on disposal of property, plant and equipment | 0 | 0* | 0 | 0.1 |
| Total operating expenses | 87 | 63* | 110.8 | 88.9 |
| Operating income | 36.5 | 69* | 5.9 | 34.3 |
| Other income/(expense), net | 2.6 | 2* | 3.4 | -5.1 |
| Pension scheme settlement charge | - | 0* | - | - |
| Interest income, net | 0.8 | 2* | 2.2 | 2.7 |
| Income before income tax expense | 39.9 | 73* | 11.5 | 31.9 |
| Income tax expense | 9.1 | 11* | -1.4 | 8.4 |
| Net income | 30.8 | 62 | 12.9 | 23.5 |
| Less net income attributable to noncontrolling interests | 0.4 | - | - | - |
| Net income attributable to innospec | 30.4 | - | - | - |
| Basic EPS | 1.23 | 2.493 | 0.52 | 0.94 |
| Diluted EPS | 1.22 | 2.477 | 0.52 | 0.94 |
| Basic Average Shares | 24,776,000 | 24,869,000 | 24,834,000 | 24,937,000 |
| Diluted Average Shares | 24,844,000 | 25,028,000 | 24,909,000 | 25,042,000 |
INNOSPEC INC. (IOSP)
INNOSPEC INC. (IOSP)